Reducing osteoporosis treatment backlog with IBEX Trueview fracture risk prediction software tool on standard plain radiographs
Reducing osteoporosis treatment backlog with IBEX Trueview fracture risk prediction software tool on standard plain radiographs
批准号:
10037108
负责人:
金额:
$44.28万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Trueview is an advanced software product that enables bone health diagnoses to be made using standard X-ray scans, rather than the specialised DXA scans currently required.The technology has been shown to provide accurate diagnosis of osteoporosis on forearm X-rays and this project will further develop the technology to allow it to be used on a wider range of body parts that can be assessed to provide a bone health diagnosis including ankle, pelvis, femur and humerus.The project will assess the performance of these developments in a human clinical study at the University of Exeter, with the final outputs supporting regulatory certification and ongoing commercialisation and adoption activities.A successful project will facilitate roll-out and adoption of a product that will have a significant impact on osteoporosis treatment waiting times and will reduce the numbers of fragility fractures incurred, along with their associated health and social care costs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
miRNA靶位点遗传多态性调控骨质疏松机理研究
-
批准号:31071097
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:雷署丰
-
依托单位: